Continuous versus Intermittent Use of Meropenem in Septic Critically Ill Patients: A Randomized Controlled Trail
Saad, S., Aglan, B., Shaboob, E., Abdelghany, H. (2024). Continuous versus Intermittent Use of Meropenem in Septic Critically Ill Patients: A Randomized Controlled Trail. EKB Journal Management System, 41(2), 38-48. doi: 10.21608/bmfj.2023.247556.1949
Saad Ibrahim Saad; Bsem Mofreh Aglan; Eslam Ali Shaboob; Hossam Helmy Abdelghany. "Continuous versus Intermittent Use of Meropenem in Septic Critically Ill Patients: A Randomized Controlled Trail". EKB Journal Management System, 41, 2, 2024, 38-48. doi: 10.21608/bmfj.2023.247556.1949
Saad, S., Aglan, B., Shaboob, E., Abdelghany, H. (2024). 'Continuous versus Intermittent Use of Meropenem in Septic Critically Ill Patients: A Randomized Controlled Trail', EKB Journal Management System, 41(2), pp. 38-48. doi: 10.21608/bmfj.2023.247556.1949
Saad, S., Aglan, B., Shaboob, E., Abdelghany, H. Continuous versus Intermittent Use of Meropenem in Septic Critically Ill Patients: A Randomized Controlled Trail. EKB Journal Management System, 2024; 41(2): 38-48. doi: 10.21608/bmfj.2023.247556.1949